Answers are grounded in this paper and cite their sources.
Schefflera heptaphylla (L.) Frodin, a medicinal plant belonging to the Araliaceae family, has been traditionally used to treat various diseases; however, the bioactivity of its essential oil has not been extensively evaluated. This study isolated the essential oil from the leaves of S. heptaphylla (SHEO), analysed its chemical components and subsequently assessed anti-inflammatory and anti- proliferative effects in vitro and in silico. As a result, the main components of SHEO, including β-myrcene (24.1%) and γ-elemene (23.6%) bound cyclooxygenase-2 and inducible nitric oxide synthase with energies ranging from -39.3 to -78.4 kcal/mol. However, SHEO moderately inhibited nitric oxide release with a value of 22.59±5.79% at 20 µg/mL. Additionally, SHEO bound to proteins related to apoptosis and migration such as B-cell lymphoma 2, B-cell lymphoma-extra large and vascular endothelial growth factor receptor 2 with binding energies of -48.1 to -99.4 kcal/mol and arrested the proliferation of SK-LU-1 and HT-29 cancer cells with IC50 values of 7.98±0.23 µg/mL and 3.96±0.16 µg/mL. These results contribute to understanding the bioactivity of SHEO, including its anti-inflammatory and anti-proliferative effects against cancer cells.
No takes yet. Share an insight, caveat, or question.
Hang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: